NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free IBB Stock Alerts $126.49 +0.82 (+0.65%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$125.05▼$126.9350-Day Range$124.64▼$140.8952-Week Range$111.83▼$141.16Volume833,050 shsAverage Volume1.53 million shsMarket Capitalization$7.03 billionAssets Under Management$6.99 billionDividend Yield0.32%Net Expense Ratio0.44% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media Get iShares Biotechnology ETF alerts: Email Address About iShares Biotechnology ETF (NASDAQ:IBB)iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More IBB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBB ETF News HeadlinesApril 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2?The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.April 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2? (IBB)The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gainsApril 28, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 28, 2024 | nasdaq.comJune 7th Options Now Available For iShares Trust - iShares Biotechnology ETF (IBB)April 19, 2024 | msn.com9 Best Biotech ETFs for 2024April 17, 2024 | nasdaq.comIBB Crosses Critical Technical IndicatorApril 10, 2024 | msn.comTop 10 best performing S&P 500 health care stocks of 2024April 8, 2024 | investing.comSemiconductors Steady, Biotech Stumbles: What's Next for These Sectors?April 28, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 2, 2024 | investing.comYields Up, US Dollar Up, Junk Bonds Tumble as New Quarter Kicks OffSee More Headlines Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings224 Fund Statistics Assets Under Management$6.99 billion Average Daily Volume$1.56 million Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume1,995 Put Options1,277 Call Options718 Short Interest8,740,000 shs Miscellaneous Outstanding Shares55,600,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.44%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.44%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.44%0.60%0.60%0.54%0.58% iShares Biotechnology ETF (IBB) Holdings & ExposureTop 10 IBB HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.54%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.32%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.23%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.17%IQVIA(NYSE:IQV)Holding Weight: 4.42%Moderna(NASDAQ:MRNA)Holding Weight: 3.71%Biogen(NASDAQ:BIIB)Holding Weight: 2.98%Mettler-Toledo International(NYSE:MTD)Holding Weight: 2.73%Illumina(NASDAQ:ILMN)Holding Weight: 2.00%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 1.97%IBB Sector ExposureIBB Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesSimilar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipSignature Wealth Management Partners LLCSold 213 shares on 4/27/2024Ownership: 0.021%Finer Wealth Management Inc.Bought 2,148 shares on 4/27/2024Ownership: 0.004%Meridian Wealth Management LLCSold 91 shares on 4/26/2024Ownership: 0.009%KG&L Capital Management LLCSold 105 shares on 4/26/2024Ownership: 0.003%Sterling Investment Counsel LLCSold 156 shares on 4/26/2024Ownership: 0.003%View All Institutional Transactions IBB ETF - Frequently Asked Questions How have IBB shares performed in 2024? iShares Biotechnology ETF's stock was trading at $135.85 at the beginning of 2024. Since then, IBB shares have decreased by 6.9% and is now trading at $126.49. View the best growth stocks for 2024 here. How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF? iShares Biotechnology ETF announced a quarterly dividend on Wednesday, March 20th. Investors of record on Friday, March 22nd will be paid a dividend of $0.126 per share on Wednesday, March 27th. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for IBB. What does IBB invest in? iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $6.99 billion assets under management. What stocks does iShares Biotechnology ETF hold? IBB invests in 224 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), IQVIA (IQV), Moderna (MRNA), Biogen (BIIB), Mettler-Toledo International (MTD), Illumina (ILMN) and Alnylam Pharmaceuticals (ALNY). What is the management fee for iShares Biotechnology ETF? iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%. When did iShares Biotechnology ETF's stock split? Shares of iShares Biotechnology ETF split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL). Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Global Assets Advisory LLC (0.87%), Raymond James & Associates (0.33%), Raymond James Financial Services Advisors Inc. (0.31%), Albion Financial Group UT (0.23%), Cumberland Advisors Inc. (0.15%) and Appleton Partners Inc. MA (0.13%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBB) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.